SAF312 Eye Drops
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SAF312 Eye Drops, covering 2024-04-18 to 2024-04-18. Get the full timeline:
Most recent: Clinical Trial Update: Study of Efficacy and Safety of SAF312 Eye Drops in Subjects With Post-operative Corneal Induced Chronic Pain (CICP) [Phase 2]